Saul J Priceman Selected Research

Saul J Priceman Research Topics

Disease

30	Neoplasms (Cancer) 01/2022 - 04/2007
6	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 05/2009
4	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 01/2018
4	Neoplasm Metastasis (Metastasis) 01/2018 - 10/2008
3	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2016
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 01/2021
2	Glioblastoma (Glioblastoma Multiforme) 10/2018 - 12/2016
2	Breast Neoplasms (Breast Cancer) 01/2018 - 09/2010
2	Ascites 01/2018 - 01/2016
2	Inflammation (Inflammations) 08/2013 - 02/2010
1	Ovarian Epithelial Carcinoma 01/2022
1	Lymphoma (Lymphomas) 01/2021
1	Colonic Neoplasms (Colon Cancer) 01/2021
1	Central Nervous System Diseases (CNS Diseases) 01/2021
1	Brain Neoplasms (Brain Tumor) 10/2018
1	Neuroblastoma 11/2017
1	Liver Neoplasms (Liver Cancer) 01/2017
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 01/2017
1	Hematologic Diseases (Blood Diseases) 11/2015
1	T-Cell Lymphoma (Lymphoma, T Cell) 07/2014
1	Obesity 08/2013
1	Insulin Resistance 08/2013
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2013
1	Atherosclerosis 02/2010
1	Vascular Tissue Neoplasms 10/2008
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2007

Drug/Important Bio-Agent (IBA)

15	Chimeric Antigen ReceptorsIBA 01/2022 - 11/2015
9	CytokinesIBA 01/2022 - 06/2014
9	AntigensIBA 01/2022 - 12/2016
3	Neoplasm Antigens (Tumor Antigens)IBA 01/2020 - 07/2014
3	Small Interfering RNA (siRNA)IBA 06/2015 - 10/2008
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
2	AntibodiesIBA 01/2022 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2017
2	AndrogensIBA 03/2015 - 10/2008
2	Macrophage Colony-Stimulating FactorIBA 03/2015 - 02/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2013 - 10/2008
2	Phosphotransferases (Kinase)IBA 09/2010 - 04/2007
2	5- (3- methoxy- 4- ((4- methoxybenzyl)oxy)benzyl)pyrimidine- 2,4- diamineIBA 09/2010 - 02/2010
2	Macrophage Colony-Stimulating Factor Receptor (Receptor, Macrophage Colony Stimulating Factor)IBA 09/2010 - 02/2010
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021
1	Cancer VaccinesIBA 01/2020
1	VaccinesIBA 01/2019
1	Recombinant ProteinsIBA 01/2019
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2018
1	Glycoproteins (Glycoprotein)IBA 01/2018
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 11/2017
1	Peptides (Polypeptides)IBA 01/2017
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2017
1	HLA-A Antigens (HLA-A)IBA 01/2017
1	Interleukin-13 Receptors (Interleukin 13 Receptor)IBA 12/2016
1	Cell Adhesion MoleculesIBA 01/2016
1	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 01/2016
1	Chemokine CXCL10IBA 08/2015
1	APTIBA 07/2014
1	CTLA-4 AntigenIBA 07/2014
1	ArginaseIBA 06/2014
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 08/2013
1	Glucose (Dextrose)FDA LinkGeneric 08/2013
1	prenylIBA 01/2013
1	icaritinIBA 01/2013
1	Cyclin EIBA 01/2013
1	FlavonoidsIBA 01/2013
1	Therapeutic UsesIBA 01/2013
1	Propranolol (Inderal)FDA LinkGeneric 09/2010
1	Adrenergic Agents (Adrenergic Drugs)IBA 09/2010
1	Apolipoproteins E (ApoE)IBA 02/2010
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 02/2010
1	ApolipoproteinsIBA 02/2010
1	Prostaglandins EIBA 02/2010
1	Green Fluorescent ProteinsIBA 05/2009
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 05/2009
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 10/2008
1	LigandsIBA 10/2008
1	Vascular Endothelial Growth Factor CIBA 10/2008
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 04/2007
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2007
1	linifanibIBA 04/2007
1	TransferasesIBA 04/2007

Therapy/Procedure

16	Therapeutics 01/2022 - 10/2008
12	Immunotherapy 01/2022 - 08/2015
2	Drug Therapy (Chemotherapy) 01/2022 - 11/2017
1	Hyperthermic Intraperitoneal Chemotherapy 01/2022
1	Precision Medicine 01/2019
1	Intravenous Administration 01/2017